Moreno, Fernando Salvador 
; Horst, Maria Aderuza; Pierri, Rodrigo de; Conti, A. de; Heidor, Renato ; Ortega, J. F; Paiva, S.A. R; Ong, Thomas Prates
Fonte: European Journal of Cancer Supplements. Nome do evento: EORTC - NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics. Unidade: FCF
Assuntos: CARCINOGÊNESE ANIMAL, QUIMIOTERÁPICOS, RATOS (EXPERIMENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORENO, Fernando Salvador et al. The p53 pathway as a molecular target for the suppressive chemopreventive action of the histone deacetylase inhibitor tributyrin in rat hepatocarcinogenesis. European Journal of Cancer Supplements. Oxford: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 03 maio 2024. , 2010APA
Moreno, F. S., Horst, M. A., Pierri, R. de, Conti, A. de, Heidor, R., Ortega, J. F., et al. (2010). The p53 pathway as a molecular target for the suppressive chemopreventive action of the histone deacetylase inhibitor tributyrin in rat hepatocarcinogenesis. European Journal of Cancer Supplements. Oxford: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Moreno FS, Horst MA, Pierri R de, Conti A de, Heidor R, Ortega JF, Paiva SAR, Ong TP. The p53 pathway as a molecular target for the suppressive chemopreventive action of the histone deacetylase inhibitor tributyrin in rat hepatocarcinogenesis. European Journal of Cancer Supplements. 2010 ; 8( 7): 203-204.[citado 2024 maio 03 ]Vancouver
Moreno FS, Horst MA, Pierri R de, Conti A de, Heidor R, Ortega JF, Paiva SAR, Ong TP. The p53 pathway as a molecular target for the suppressive chemopreventive action of the histone deacetylase inhibitor tributyrin in rat hepatocarcinogenesis. European Journal of Cancer Supplements. 2010 ; 8( 7): 203-204.[citado 2024 maio 03 ]
